Элиминация белковых фракций при проведении экстракорпоральных методов детоксикации онкологическим больным с гнойно-септическими осложнениями
Диссертация
В настоящее время одной из наиболее актуальных проблем современной медицины является сепсис, летальность при котором, несмотря на интенсивную терапию, достигает 40−90% в зависимости от этиологических причин и степени органных нарушений. В онкологических клиниках проблема сепсиса особенно значима, так как присущие опухолевому процессу нарушения различных звеньев гомеостаза усугубляются инвазивными… Читать ещё >
Список литературы
- Белобородов Б.В. Сепсис современная проблема клинической медицины // Русский медицинский журнал. — 1997. — Т.24. — С. 15 891 596.
- Белобородов Б.В. Сепсис: что делать? // Медицина для всех. 1998. №−5-С. 5−10.
- Белобородов Б.В. Проблема полиорганной недостаточности у больных с сепсисом // Инфекция и антимикробная терапия. 2001. № 3. — С. 6869.
- Белобородов В.В. Актуальные вопросы диагностики и лечения сепсиса. // Consilium Medicum. — 2001. № 6. — Т.З.
- Белобородова Н.В., Богданов Н. В., Черненькая Т. В. Алгоритмы антибиотикотерапии // М.: Медицина, 1999. 112 с.
- Белобородова Н.В., Исаков Ю. Ф. Сепсис у детей // М.: Макеев, 2001. -369 с.
- Белломо Р., Ронко К. Очищение крови при сепсисе: целесообразная гипотеза или напрасная трата времени? // Анест. реаним. 2002. №. 2. — С. 76−79.
- Бирюкова Л.С., Володяева Е. Б., Фетисова Е. В., Пивник А. В., Марголин О. В. Острая и хроническая почечная недостаточность у больных миеломной болезнью // Тер. арх. — 1999. № 71. — С. 58−64.
- Гельфанд Б.Р., Филимонов М. И., Бурневич С. З. Абдоминальный сепсис // Русский медицинский журнал. — 1998. № 6. — С. 697−706.
- Ю.Гельфанд Б. Р., Бурневич С. З. Гельфанд Е.Б. Антибактериальная терапия абдоминального сепсиса // Вестн. инт. терапии. 1998. № 2 -С. 32−8.
- Громова Е.Г., Горобец Е. С., Свиридова С. П., Фигурин К. М. Редкий случай БЦЖ-вакцинального сепсиса у больного раком мочевого пузыря // Анестезиология и реаниматология. — 1997. № 6. — С. 54−55.
- Громова Е.Г. Экстракорпоральные методы детоксикации в комплексе интенсивной терапии онкологических больных // Дисс. докт. мед. наук. Москва. 2004. — 254 с.
- Давыдовский И. В. Учение об инфекции // М., Медицина, 1956. 158 с.
- Ковальчук J1.B., Соболев Б. Н., Ганковская J1.B., Юдин А. А. Анализ молекулярного взаимодействия в системе IL-1|3—IL-lra—IL-1R // Иммунология. — 2001. № 1. — С. 6−10.
- Крыжановский Г. Н. Некоторые общебиологические закономерности и базовые механизмы развития патологических процессов // Арх. патол. 2001. № 6. — С.44−49.
- Мороз В.В., Лукач В. Н., Шифман Е. М., Долгих В. Т., Яковлева И. И. Сепсис. Клинико-патофизиологические аспекты интенсивной терапии. Руководство для врачей / П.: ИнтелТек, 2004. 290 с.
- Стилиди И.С. Стратегия хирургии рака пищевода. 1999 2001гг.: Автореф. дисс. докт. мед. наук. Москва. 2002. -20 с.
- Тимохов B.C., Яковлева И. И., Калашникова Е. А., Ипатьева Е. И. Содержание в плазме цитокинов и их клиренс при постоянной132гемофильтрации у больных с сепсисом и полиорганной недостаточностью // Анестезиология и реаниматология. — 1997. № 3. — С. 59−62.
- Тугуз А.Р. Иммунопатогенез ранних послеоперационных осложнений у онкологических больных // Дисс.. .докт.мед.наук. Москва. 2002. — 217 с.
- Ярилин А.А. Основы иммунологии // М., Медицина, 1999. — 608 с.
- Abraham е., Marshall J.C. Sepsis and mediator-directed therapy: rethinking the target populations. Mediator-directed therapy in sepsis: rethinking the target populations // Mol. Med. Today. — 1999. Vol.5. — P. 56−8.
- Amyot S.L. Myoglobin clearance and removal during continuous venovenous hemofiltration // J. Int. Care. Med. — 1999. — Vol. 25. — P. 1169−1172.
- An American College of Chest Physicians. Society of Critical Care Medicine Consensus Conference — Northbrook. — 1991. — 243 p.
- Anaissie E.J., Rex J.H., Uzun O., Vartivarian S. Predictors of adverse outcome in cancer patients with candidemia. // Am. J. Med. — 1998. — Vol.3. —P. 238−45.
- Asanuma Y., Sato Т., Kotanagi H., Yamamoto Y., Nakae H. Treatment of Multiple Organ Failure through sepsis by surgery and blood purification // Ther. Apher. — 2004. — Vol. 3. — P. 185−9.
- Barriere S.L., Lowry S.F. An overview of mortality risk prediction in sepsis // Crit. Care Med. — 1995. — Vol. 23. — P. 376−93.
- Bellomo R., Tipping P., Boyce N. Tumor necrosis factor clearances during veno-venous hemodiafiltration in the critically ill // Trans. Am. Soc. Artif. Intern. Organs. — 1991. — Vol. 37. — P. 322−3.
- Bellomo R., Tipping P., Boyce N. Interleukin-6 and Interleukin-8 exstraktion during continuous venovenous hemodiafiltration in septic acute renal failure // Ren. Fail. — 1995. — Vol. 17. — P. 457−66.
- Bellomo R., Tipping P., Boyce N. Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. // Crit. Care Med. — 1993. — Vol. 21. — P. 522−6.
- Brun-Buisson C., Doyon F., Carlet J., et al. Incidence, risk factors and outcome of severe sepsis and septic shoe in adults. // Jama. — 1995. — Vol. 274.—P. 968−74.
- Bellomo R. Continuous hemofiltration as blood purification in sepsis. // New Horizons. — 1995. — P.732−737.
- Bellomo R., Ronco C. Continuous renal replacement therapy in the intensive care unit. // Intens. Care Med. — 1999. — Vol. 25. — P.781−789.
- Bellomo R., Honore P.M., Matson J., Ronco C., Winchester J. Extracorporeal blood treatment (EBT) methods in SIRS/Sepsis // Int. J. Artif. Organs. — 2005. — Vol. 28. — P. 450−8.
- Beerenhout Ch.H., Kooman J.P.- Luik A.J., Jeuken-Mertens S.G.J., van der Sande F.M., Leunissen K.M.L. Optimizing renal replacement therapy—a case for online filtration therapies? // Nephrol. Dial. Transplant. — 2000. — Vol. 15. —P. 49−54.
- Bone R.C., Grodzin Ch.J., Balk R.A. Sepsis: A New Hypothesis for Pathogenesis of the Disease Process // Chest. — 1997. — Vol. 112. — P. 235−43.
- Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. // Anal. Biochem. — 1976. — Vol. 72. — P. 248−254.
- Broader W., Williams D., Pretus H. Beneficial effect of enhanced macrophage function in the trauma patient // Ann. Surg. — 1990. — Vol. 211. —P. 605−12.
- Brockhaus M. Soluble TNF receptor: what is the significance? // Int. Care Med. — 1997. — Vol. 23. — P. 808−9.
- Calandra Т., Baumgather J., Grau G., Wu M., Glauser M. Prognostic values of tumor necrosis factor/cachectin, interleukin 1, interferon-a andinterferon-y in the serum of patients with septic shock // J. Infect. Dis. — 1990. —Vol. 161.-P. 982−987.
- Chackhiani I., Gurlich R., Maruna P., Frasko R., Lidner J. The postoperative stress response and its reflection in cytokine network and leptin plasma levels // Physiol. Res. — 2005. — Vol. 54. — P. 279−85.
- Cipolle M.D., Pasquale N.M., Cerra F.B. Secondary organ dysfunction: from clinical perspectives to molecular mediators // Crit. Care. Clin. — 1993. —Vol. 9. —P. 261−98.
- Cole L., Bellomo R., Journois D., Davenport P., Baldwin I., Tipping P. High-volume haemofiltration in human septic shock // Int. Care. Med. — 2001. — Vol. 27. — P. 978−86.
- Cole L., Bellomo R., Hart G., Journois D., Davenport P., Tipping P., Ronco C. A phase II randomized, controlled trial of continuous hemofiltration in sepsis // Crit. Care. Med. — 2002. — Vol. 30. — P. 100−6.
- Cole L., Bellomo R., Davenport P., Tipping P., Uchino S., Tetta C., Ronco C. The effect of coupled haemofiltration and adsorption on inflammatory cytokines in an ex vivo model // Nephrol. Dial. Transplant. — 2002. — Vol. 17. —P. 1950−6.
- Cole L., Bellomo R., Davenport P., Tipping P., Ronco C. Cytokine removal during continuous renal replacement therapy: an ex vivo comparison ofconvection and diffusion // Int. J. Artif. Organs. — 2004. — Vol. 27. — P. 388−97.
- Cole L., Bellomo R., Hart G. Journois D. A phase II randomized, controlled trial of continuous hemofiltration in sepsis // Crit. Care Med. — 2002. — Vol. 30. —P. 100−6.
- Combarnous F., Tetta C., Cellier C.C., Wratten M.L., Custaud, De Catheu Т., Fouque D., David S., Carraro G., Laville M. Albumin loss in on-line hemodiafiltration // Int. J. Artif. Organs. — 2002. — Vol. 25. — P. 203 209.
- Curfs J.H.A.J., Meis J., Hoogkamp-Korstanje J.A.A. A Primer on Cytokines: Sources, Receptors, Effects, and Inducers // Clin. Microbiol. Rev. — 1997. — Vol. 10. — P. 742−780
- Dahaba A.A., Elawdy G.A., Rehark P.H., List W.F. Procalcitonin and proinflammatory cytokine clearance during continuous venovenous haemofiltration in septic patients // Anaesth. Int. Care — 2002. — Vol. 30. — P. 269−74.
- Dahaba A.A., Rehak P.H., List W.F. Procalcitonin and C-reactive protein plasma concentrations in nonseptic uremic patients undergoing hemodialysis // Int. Care Med. — 2003. — Vol. 29. — P. 579−83
- Damas P., Ledoux D., Nys M., Vrindts Y., De Groote D., Franchimont P., Lamy M. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity // Ann. Surg. — 1992. — Vol. 215. — P. 356−62.
- Damas P., Canivet J.L., de Groote D., Vrindts Y., Albert A., Franchimont P., Lamy M. Sepsis and serum cytokine concentrations// Crit. Care. Med. — 1997. — Vol. 25. — P. 405−12.
- Davenport A., Roberts N.B. Amino acid losses during continuous high-flux hemofiltration in the critically ill patient // Crit. Care Med. — 1989. — Vol. 17. —P. 1010−1014.
- Debets J.M., Kampmeijer R., van der Linden M.P., Buurman W.A. van der Linden CJ. Plasma tumor necrosis factor and mortality in critically ill septic patients // Crit. Care Med. — 1989. — Vol. 17. — P. 489−94.
- Dellinger R.P., Carlet J.M., Masur H., Gerlach H., Calandra Т., Cohen J., et all. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic schock. // Crit. Care Med. — 2004. — Vol. 32. — P. 1448.
- DinareIlo C.A., Gelfand J.A., Wolff S.M. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome // JAMA —1993. —Vol. 269. —P. 1829−35.
- Elias M., Bisharat N., Goldstein L.H., Raz R., Saliba W. Pneumococcal sepsis due to functional hyposplenism in a bone marrow transplant patient. // Eur. J. Clin. Microbiol. Infect. Dis. — 2004. — Vol. 23. — P. 2121.
- Ford H.R., Hoffman R.A., Wing E.J. Characterization of wound cytokines in the sponge matrix model // Arch. Surg. — 1989. — Vol. 124. — P. 142 228.
- Fukushima R., Alexander J.W., Gianotti L. Isolated pulmonary infection acts as a source of systemic tumor necrosis factor // Crit. Care. Med. —1994. —Vol. 22. —P. 114−20.
- Gangji A.S., Rabbat C.G. Margetts P.J. Benefit of continuous renal replacement therapy in subgroups of acutely ill patients: a retrospective analysis // Clin. Nephrol. — 2005. — Vol. 63. — P. 267−75.
- Gardlund В., Sjolin J., Nilsson A., Roll M., Wickerts C.J., Wretlind B. Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity //J. Infect. Dis. — 1995. — Vol. 172. — P. 296−301.
- Gasche C., Lomer M.C.E., Cavill I., Weiss G. REVIEW. Iron, anaemia, and inflammatory bowel diseases // Gut. — 2004. — Vol. 53. — P. 1190−1197.
- Gashe Y., Pascual M., Suter P.M. Complement depletion during haemofiltration with polyacrilonitrile membranes // Nephrol. Dial. Transplant. —1996. —Vol. 11. —P. 117−119.
- Gassas A., Grant R., Richardson S., Dupuis L.L., Doyle J., et al. Predictors of viridans streptococcal shock syndrome in bacteremic children with cancer and stem-cell transplant recipients // J. Clin. Oncol. — 2004. — Vol. 22. —P. 1222−7.
- Gebhardt C., Kraus D. Acute pancreatitis — conservative versus surgical therapy // Wien Med. Wochenschr. — 1997- 147 (1): 2−5.
- Gianotti L., Fortis C., Braga M., Gentilini O., Vignali A., Di Carlo V. Radical oncologic surgery affects the circulatory levels of interleukin-10 // J. Surg. Oncol. — 1997. — Vol. 66. — P. 244−7.
- Gibbons R.A., Martinez O.M., Lim O.C. Reduction in HLA-DR, HLA-DQ, and HLA-DP expression by Leu-M31 cells from the peripheral blood of patients with thermal injury // Injury — 1989. — Vol. 19. — P.263−66.
- Girardin E., Dayer J.M. Cytokines and antagonists in septic shock // Schweiz. Med Wochenschr. — 1993. — Vol. 20. — P.480−91.
- Gold J.S., Bayar S., Salem R.R. Association of Streotococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy // Arch. Surg. — 2004. — Vol. 139. — P. 760−5.
- Goris J.A., te Boekhorst T.P.A., Nuytinck J.K.S. Multiple organ failure: generalized autodestructive inflammation? // Arch. Surg. — 1985. — Vol. 120. —P. 1109−15.
- Grootendorst A.F., van Bommel E.F. The role of hemofiltration in the critically ill intensive care unit patients: present and future // Blood Purif. — 1993. — Vol. 11. — P. 209−223.
- Grootendorst A.F. The potential role of hemofiltration in the treatment of patients with septic shock and multiple organ dysfunction syndrome // Adv. Ren. Repl. Ther. — 1994. — Vol. 1. — P. 176−84.
- Grootendorst A.F., van Bommel E.F. Continuous hemofiltration // N. Engl. J. Med. — 1997. — Vol. 337. — P. 713.
- Guenoun Т., Journois D., Satran D. / Hemofiltration during severe sepsis or multiorgan failure syndrome // Nephrology — 1998. — Vol. 19. — P. 8388.
- Guesaldo L., Cirillo P., Netti S., Centone D., Perego A.F. Sepsis: from pathophysiology to treatment // G. Ital. Nephrol. — 2006. — Vol. 23. — P. 74−78.
- Haraldsen P., Isaksson K., Zdanowsky Z., Andersson R. Abdominal sepsis in the surgical intensive care unit // Crit Care. — 1998. — Vol. 2. — P. 144.
- Hergert-Rosental S., Uppenncamp M., Beelen D., Kohl D., Kribben A. / Renal complications of high-dose chemotherapy and peripheral blood stem cell transplantation // Nephron. — 2000. — Vol. 84. — P. 136−41.
- Hirasawa H., Sugai Т., Ohtake Y., Oda S., Matsuda K., Kitamura N. Blood purification for prevention and treatment of multiple organ failure // W. J. Surg. — 1996. — Vol. 20. — P. 482−486.
- Hirasawa H., Sugai Т., Oda S., Shiga H., Matsuola K., Ueno H. Prevention and treatment of postoperative septic MOF and DIC and efficacy of blood purification // Nippon Geka Gakkai Zasshi. — 1996. — Vol. 97. — P. 1079−84.
- Hirasava K., Sugai Т., Oda S. Acute renal failure following surgical insult // Nippon Geka Gakkai Zasshi. — 1996. — Vol. 97. — P. 765−770.
- Hoffman J.N., Hartl W.H., Deppich R., Faist E., Jochum M., Inthorn D. Effect of hemofiltration on hemodynamic and systemic concentrations of anafilatoxins and cytokines in human sepsis // Int. Care Med. — 1996. — Vol. 22. —P. 1360−1367.
- Ibbotson G.C., Wallace J.L. Beneficial effects of prostaglandin E2 in endotoxin shock are unrelated to effects of PAF-acether synthesis // Prostaglandins — 1989. — Vol. 37. — P. 237−50.
- Iwai H., Nagaki M., Naito Т., Ishiki Y., Murakami N., Sugihara J., Muto Y., Moriwaki H. Removal of endotoxin and cytokines by plasma exchange in patients with acute hepatic failure // Crit. Care Med. — 1998. — Vol. 26. —P. 873−6.
- Janbon В., Vuillez J.P., Carpentier F., Barnoud D., Andre-Poyaud P., Barbe G., Guignier M. Removal of circulating tumor necrosis factor. Its role in septic shock treatment // Ann. Med. Interne. — 1992. — Vol. 143.1. Suppl 1. —P. 13−6.
- Joyce D.E., Gelbert L., Ciaccia A., DeHoff В., Grinnell B.W. Gene expression profile of antithrombotic protein с defines new mechanisms modulating inflammation and apoptosis // J. Biol. Chem. — 2001. — Vol. 276. —P. 11 199−11 203.
- Kabir S., Daar G.A. Serum levels of interleukin-1, interleukin-6 and tumour necrosis factor-alpha in patients with gastric carcinoma // Cancer Lett. — 1995. —Vol. 16. —P. 207−12.
- Kaplan A.A. Extracorporeal blood purification in the treatment of acute renal failure with multiorgan involvement // Blood Purif. — 1996. — Vol. 14. —P. 86−93.
- Kaplan A.A., Epstein M. Extracorporeal blood purification in the management of patients with hepatic failure // Semin. Nephrol. — 1997. — Vol. 17. —P. 576−82.
- Keogh C., Fong Y., Marano M.A. Identification of a novel tumor necrosis factor cachectin from the livers of burned and infected rats // Arch. Surg. —1990. —Vol. 125. —P. 79−85.
- Kielstein J.T., Imparaim В., Simmel S. Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical142dimethylarginine in humans // Circulation. — 2004. — Vol. 109. — P. 172 177.
- Kooman J.P., van Bommel E. F, van der Sande F.M., Leunissen K.M. Acute renal replacement therapy in the intensive care unit // Ned. T. Gene. — 2001. —Vol. 145. —P. 2317−21.
- Kooman J.P., van der Sande F.M., Beerenhout C.M. On-line filtration therapies: emerging horizons // Blood Purif. — 2006. — Vol. 24. — P. 15 962.
- Koperna Т., Vogl S.E., Poschl G.P., Hamilton G., Roder G., Germann P. Cytokine patterns in patients who undergo hemofiltration for treatment of multiple organ failure // W. J. Surg. — 1998. — Vol. 22. — P.443−447.
- Kremery V., Spanik S., Mrazova M., Trupl J., Grausova S., et al. Bacteremias caused by Escherichia coli in cancer patients — analysis of 65 episodes // Int. J. Infect. Dis. — 2002. — Vol. 6. — P. 69−73.
- Kupper T.S., Deitch E.A., Baker C.C. The human burn wound as a primary source of interleukin-1 activity // Surgery. — 1996. — Vol. 100. — P. 409−14.
- Kurata H., Yoshiya N., Ikarashi H., Kaneko Т., Kodama S., Tanaka K., Suzuki K., Yoshizawa H., Cho Т., Suzuki E., et al. Pharmacokinetics of carboplatin in a patient under hemodialysis // Gan To Kagaku Ryoho. — 1994. —Vol. 21. —P. 547−50.
- Kumar As., Kumar An., Michael P. Human serum from patients with septic shock activates transcription factors STAT1, IRF1, and NF-кВ and induces apoptosis in human cardiac myocytes // J. Biol. Chem. — 2005. — Vol. 280. — P. 42 619^42626.
- Laemmli U.K. Cleavage of structural proteins during the assembly of head of bacteriophage T4 // Nature. — 1970. — Vol. 227. — P. 680−685.
- Ledingham I., Ramsay G. Hypovolaemic shock // Br. J. Anaesth. — 1986. — Vol. 58. —P. 169−189.
- Lefler D.M., Pafford R.G., Black N.A., Raymond J.R., Arthur J.M. / Identification of proteins in slow continuous ultrafiltrate by reversed-phase chromatography and proteomics // J. Prot. Res. — 2004. — Vol. 3. — P. 1254−1260.
- Leonardo M.J., Baltimore D. NFkB: pleiotropic mediator of inducible and tissue-specific gene control // Cell. — 1989. — Vol. 58. — P. 227−229.
- Lewis R.A., Austen K.F., Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway: biochemistry and relation to pathobiology in human diseases // N. Engl. J. Med. — 1990. — Vol. 323.1. P. 645−55.
- Lien E., Ingalls R.R. Toll like receptors // Crit. Care Med. — 2002.1. Vol. 30 —P. Sl-Sll.
- Livingston D.H., Appel S.H., Wellhausen S.R. Depressed interferon-gamma production and monocyte HLA-DR expression after severe injury // Arch. Surg. — 1988. — Vol. 123. — P. 1309−13
- Lonnemann G., Koch K.M. p2-microglobulin amyloidosis: effects of ultrapure dialysate and type of dialyser membrane // J. Am. Soc. Nephrol. —2002. — S72-S77.
- Lopez-Bojorquez L.N., Dehesa A.Z., Reyes-Teran G. Molecular mechanisms involved in the pathogenesis of septic shock // Arch. Med. Res.2004. — Vol. 35. — P.465−79.
- Manns M., Sigler M.H., Teehan B.P. Continuous renal replacement therapies: an update // Am. J. Kidney Dis. — 1998. — Vol. 32. — P. 185 207.
- Martin C., Boisson C., Haccoun M., Thomachot L. Patters of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma // Crit. Care Med. — 1997, —Vol. 25. —P. 1771−3.
- Matsuda K, Hirasawa H, Oda S, Shiga H, Nakanishi K. Current topics on cytokine removal technologies // Ther. Apher. — 2001. — Vol. 5. — P. 306−14.
- Meduri G.U., Kohler G., Headley S. Inflammatory cytokines in the BAL of patients with ARDS: persistent elevation over time predicts a poor outcome//Chest. — 1995. — Vol. 108. —P. 1303−14.
- Molina H., Bunkenborg J., Reddy G. H., Muthusamy В., Scheel P. J., Pandey A. A Proteomic Analysis of Human Hemodialysis Fluid // Mol. Cell. Proteomics. — 2005. — Vol. 4. — P. 637 650.
- Morgera S., Rocktaschel J., Haase M., Lehmann C., von Heymann C., et all. Intermittent high permeability hemofiltration in septic patients with acute renal failure // Int. Care Med. — 2003. — Vol. 29. — P. 198 995.
- Munoz C., Carlet J., Fitting C. Dysregulation of in vitro cytokine production by monocytes during sepsis // J. Clin. Invest. — 1991. — Vol. 88.—P. 1747−54.
- Nakae H., Asanuma Y., Tajimi K. Cytokine removal by plasma exchange with continuous hemodiafiltration in critically ill patients // Ther Apher. — 2002. — Vol. 6. — P. 419−24.
- Nakazaki H. Preoperative and postoperative cytokines in patients with cancer // Cancer. — 1992. — Vol. 70. — P. 709−13.
- Nguen H.B., Rivers E.P., Abrahamian F.M. Severe sepsis and septic sock: review of the literature and emergency department management guidelines // Ann. Emerg. Med. — 2006. — Vol. 48. — P. 28−54.
- Oberholzer A., Souza S.M., Tschoeke S.K. Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis // Shock. — 2005. — Vol. 23. — P. 488−93.
- Odetti P., Cosso L., Pronzato M.A., Dapino D., Gurreri G. / Plasma advanced glycosylation end-products in maintenance haemodialysis patient // Nefrol. Dial. Transplantant. — 1995. — Vol. 10. — P. 2110−13.
- Parillo J.E. Pathogenetic mechanisms of septic shock // N. Engl, J. Med. — 1993. — Vol. 328. — P. 1471−1477.
- O’Reilly 1 D.A., Roberts J.R., Cartmell M.T., Demaine A.G., Kingsnorth A.N. Heat Shock Factor-1 and Nuclear Factor-kappaB Are Systemically Activated in Human Acute Pancreatitis // J. Pancreas. — 2006. —Vol.7. —P. 174−184.
- Petrak R.A., Balk R.A., Bone R.C. Prostaglandins, cyclo-oxygenase inhibitors, and thromboxane synthesis inhibitors in the pathogenesis of multiple organ failure // Crit. Care. Clin. — 1999. — Vol. 35. — P. 303−14.
- Pinsky M.R., Vincent J.-L., Deviere J. Serum cytokine levels in human septic shock: relation to multiple-system organ failure and mortality // Chest. — 1993. — Vol. 103. — P. 565−75.
- Pinsky M. Pathophysiology of sepsis and multiple organ failure: pro-versus anti-inflammatory aspects. Review // Contrib. Nephrol. — 2004. — Vol. 144. —P. 31−43.
- Puren A J., Feldman C., Savage N. Patterns of cytokine expression in community-acquired pneumonia // Chest. — 1995. —Vol. 107. — P. 134 249.
- Quinn J.V., Slotman G.J. Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock // Crit. Care Med. — 1999. — Vol. 27. — P. 2485−94.
- Raad I., Hanna H., Boktour M., Girgawy E., Danavi H., et al. Management of central venous catheters in patients with cancer and candidemia // Clin. Infect. Dis. — 2004. — Vol. 38. — P. 1119−27.
- Riche F.C., Cholley B.P., Panis Y.H. Inflammatory cytokine response in patients with septic shock secondary to generalized peritonitis // Crit. Care. Med. — 2000. — Vol. 28. — P. 433−7.
- Rinaldo J.E., Gorry M., Streiter R. Effect of endotoxininduced cell injury on 70-kD heat shock proteins in bovine lung endothelial cells // Cell. Mol. Biol. — 2000. — Vol. 3. — P. 207−16.
- Rockel A., Hertel J., Fiegel P., Abdelhamid S., Panitz N., Walb D. Permeability and secondary membrane formation of a high flux polysulfone hemofilter // Kidney Int. — 1986. — Vol. 30. — P. 429−432.
- Ronco C., Bellomo R., Ricci Z. Continuous renal replacement therapy in critically ill patients // Nephrol. Dial. Transplant. — 2001. — Vol. 16. — Suppl 5. — P. 67−72.
- Ronco C., Ricci Z., Bellomo R. Importance of increased ultrafiltration volume and impact on mortality: sepsis and cytokine story and the role for CWH // EDTNA ERCA J. — 2002. — Suppl 2. — P. 138.
- Santoro A., Canova C., Mancini C., Deppisch R., Beck W. Protein loss in on-line hemofiltration // Blood Purif. — 2004. — Vol. 22. — P. 261 268.
- Sauder D.N., Semple J., Truscott D. Stimulation of muscle protein degradation by murine and human epidermal cytokines: relationship to thermal injury // J. Invest. Dermatol. — 1996 — Vol. 87. — P. 711−14.
- Schildberg F.W., Inthorn D. Intensive therapy in surgery. Value, goals and outcome // Langenbecks Arch Chir. Suppl. Kongressbd. — 1996. — Vol. 113. —P. 275−282.
- Sigurdsson G.H., Christenson J.T., Bader el-Rakshy M. Intestinal platelet trapping after traumatic and septic shock: an early sign of sepsis and multiorgan failure in critically ill patients? // JAMA — 1992. — Vol. 20. — P. 458−67.
- Sims J.E., Giri J.D. Dower S.K. The two interleukin-1 receptors play different roles in IL-1 actions // Clin. Immunol. Immunopathol. — 1994. — Vol. 72. —P. 9−14.
- Stephens K.E., Ishikaza A., Larrick J.W. Tumor necrosis factor causes increased pulmonary permeability and edema: comparison to septic acute lung injury // Am. Rev. Respir. Dis. — 1999. — Vol. 137. — P. 1364−70.
- Storck M., Hartl W.H., Zimmerer E., Inthorn D. Comparison of pump-driven and spontaneous continuous hemofiltration in postoperative acute renal failure // Lancet. — 1991. — Vol. 337 (8739). — P.452−455.
- Tetta С., Cavaillon J.M., Gamussi G., Lonnemann G.F., Brendolan A., Ronco C. Continuous plasma filtration couple with sorbents // Kidney Int. — 1998. — Vol. 53 (suppl. 66). — P. 186−189.
- Tetta C., Bellomo R., Ronco C. Artificial organ treatment for multiple organ failure, acute renal failure, and sepsis: recent new trends // Artif. Organs. — 2003. — Vol. 27. — P. 202−13.
- Tetta C., Bellomo R., Kellum J., Ricci Z., Rohlmeier R., et al. High volume hemofiltration in critically ill patients: why, when and how? Sepsis, kidney and multiple organ disfunction // Contributions to Nephrology. — 2004. — Vol. 144. — P. 364−75.
- Thijs L.G., Hack C.E. Time course of cytokine levels in sepsis // Intensive Care Med. — 1995. — Vol. 21. — Suppl 2. — P. S 258 S263.
- Tracey K.J., Lowry S.F., Ceremi A. Cachectin/TNF-alpha in septic shock and adult respiratory distress syndrome // Am. Rev. Respir. Dis. — 1998. —Vol. 138. —P. 1377−79.
- Waida Z., Wisocki T. Continuous arteriovenous hemofiltration in the management of patients with shock and multiorgan insufficiency syndrome. // Wiad. Lek. — 1997. — Vol. 50. — Suppl. 1. — P. 190−7.
- Wakefield C.H., Carey P.D., Foulds S. Changes in major histocompatibility complex class II expression in monocytes and T cells of patients developing infection after surgery // Br. J. Surg. — 1993. — Vol. 80.—P. 205−09.
- Weksler N., Chorni I., Gurman G.M., Shapira A.R., Gotloib L. Continuous venovenous hemofiltration improves intensive care unit, but not hospital survival rate, in nonoliguric septic patients // J. Crit. Care. — 2001. — Vol. 16. —P. 69−73.
- Wilson P.G., Manji M., Neoptolemos J.P. Acute pancreatitis as a model of sepsis // J. Antimicrob. Chemother. — 1998. — Vol. 41. — P. 51 -63.
- Winchester J.F., Kellum J.A., Ronco C., Brady J.A., Quartarato P.J., Sals J.A., Levin N.W. Sorbents in acute renal failure and the systemic inflammatory response syndrome // Blood Purif. — 2003. — Vol. 21. — P. 79−84.
- Wheller D.C., Feehally J., Walls J. High risk acute renal failure // J. Med. — 1986. —Vol.61. —P. 977−984.
- Whitchack E. Sepsis Mechanism of microbial disease. 2nd Ed. Schechter M., Medoff G., Eisenstein B.I. — Baltimore. — 1993. — 973 p.
- Wilson P.G., Manji M., Neoptolemos J.P. Acute pancreatitis as a model of sepsis // J. Antimicrob. Chemother. — 1998. — Vol. 41. — P. 51 -63.
- Winchester J.F., Kellum J.A., Ronco C., Brady J.A., Quartarato P.J., Sals J.A., Levin N.W. Sorbents in acute renal failure and the systemic inflammatory response syndrome // Blood Purif. — 2003. — Vol. 21. — P. 79−84.
- Xiao W. Advances in NF-kappaB signaling transduction and transcription //Cell. Mol. Immunol. — 2004. — Vol. 1. — P. 425−35.
- Zeerlender S., Hack C.E., Wuillemin W.A., Dessiminated intravascular coagulation in sepsis // Chest. — 2005. — Vol. 128. — P. 2864−75.
- Zuckerman S.H., Bendele A.M. Regulation of serum tumor necrosis factor in glucocorticoid-sensitive and -resistant rodent endotoxin shock models // Infect. Immun. — 1999. — Vol. 57. — P. 3009−13.